Logo image of NNY

NUVEEN NEW YORK MUNI VAL (NNY) Stock Price, Quote, News and Overview

NYSE:NNY - New York Stock Exchange, Inc. - US67062M1053 - Currency: USD

8.07  0 (0%)

Fundamental Rating

2

Overall NNY gets a fundamental rating of 2 out of 10. We evaluated NNY against 0 industry peers in the Unkown industry. NNY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NNY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NNY had positive earnings in the past year.
In multiple years NNY reported negative net income over the last 5 years.
In multiple years NNY reported negative operating cash flow during the last 5 years.
NNY Yearly Net Income VS EBIT VS OCF VS FCFNNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

Industry RankSector Rank
ROA 3.01%
ROE 3.02%
ROIC 3.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NNY Yearly ROA, ROE, ROICNNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

NNY's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of NNY has remained more or less at the same level.
In the last couple of years the Gross Margin of NNY has remained more or less at the same level.
Industry RankSector Rank
OM 87.04%
PM (TTM) 66.23%
GM 88.61%
OM growth 3Y0.64%
OM growth 5Y0.15%
PM growth 3YN/A
PM growth 5Y-3.75%
GM growth 3Y0.79%
GM growth 5Y0.31%
NNY Yearly Profit, Operating, Gross MarginsNNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

More info and screens

6

2. Health

2.1 Basic Checks

NNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NNY Yearly Shares OutstandingNNY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
NNY Yearly Total Debt VS Total AssetsNNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 152.54 indicates that NNY is not in any danger for bankruptcy at the moment.
NNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 152.54
ROIC/WACCN/A
WACCN/A
NNY Yearly LT Debt VS Equity VS FCFNNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

NNY has a Current Ratio of 5.00. This indicates that NNY is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 5.00 indicates that NNY has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5
Quick Ratio 5
NNY Yearly Current Assets VS Current LiabilitesNNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for NNY have decreased strongly by -47.06% in the last year.
The earnings per share for NNY have been decreasing by -16.55% on average. This is quite bad
The Revenue has been growing slightly by 3.80% in the past year.
Measured over the past years, NNY shows a decrease in Revenue. The Revenue has been decreasing by -9.64% on average per year.
EPS 1Y (TTM)-47.06%
EPS 3YN/A
EPS 5Y-16.55%
EPS Q2Q%-72.22%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-12.15%
Revenue growth 5Y-9.64%
Sales Q2Q%2.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NNY Yearly Revenue VS EstimatesNNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.89, which means the current valuation is very expensive for NNY.
When comparing the Price/Earnings ratio of NNY to the average of the S&P500 Index (26.86), we can say NNY is valued inline with the index average.
Industry RankSector Rank
PE 29.89
Fwd PE N/A
NNY Price Earnings VS Forward Price EarningsNNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNY Per share dataNNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.35%, NNY is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.43, NNY pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.35%

5.2 History

NNY has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NNY Yearly Dividends per shareNNY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

NNY has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-124.7%
EPS Next 2YN/A
EPS Next 3YN/A
NNY Yearly Income VS Free CF VS DividendNNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

More info and screens

NUVEEN NEW YORK MUNI VAL

NYSE:NNY (6/26/2025, 8:13:05 PM)

8.07

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners25.92%
Inst Owner Change-14.33%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap152.44M
Analysts84
Price TargetN/A
Short Float %0.07%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 4.35%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-124.7%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-13 2025-06-13 (0.0295)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.89
Fwd PE N/A
P/S 19.95
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)0.27
EY3.35%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.4
BVpS8.87
TBVpS8.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 3.02%
ROCE 3.97%
ROIC 3.14%
ROICexc 3.16%
ROICexgc 3.16%
OM 87.04%
PM (TTM) 66.23%
GM 88.61%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.64%
OM growth 5Y0.15%
PM growth 3YN/A
PM growth 5Y-3.75%
GM growth 3Y0.79%
GM growth 5Y0.31%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5
Quick Ratio 5
Altman-Z 152.54
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.06%
EPS 3YN/A
EPS 5Y-16.55%
EPS Q2Q%-72.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-12.15%
Revenue growth 5Y-9.64%
Sales Q2Q%2.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.74%
EBIT growth 3Y-11.58%
EBIT growth 5Y-9.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.11%
FCF growth 3YN/A
FCF growth 5Y8.5%
OCF growth 1Y177.11%
OCF growth 3YN/A
OCF growth 5Y8.5%